InvestorsHub Logo
Followers 77
Posts 3964
Boards Moderated 0
Alias Born 08/09/2004

Re: wesley_ post# 2338

Wednesday, 05/29/2019 10:47:49 AM

Wednesday, May 29, 2019 10:47:49 AM

Post# of 2536
GENE .69 , 2nd IPO was recently priced at .80..so bargain price here :

Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE) is a diversified molecular diagnostics company. GTG offers cancer predictive testing and assessment tools to help physicians proactively manage patient health. The Company’s lead products GeneType for Breast Cancer and ‘GeneType for Colorectal Cancer’ are clinically validated risk assessment tests for non-hereditary breast cancer and are first in class.

Genetic Technologies is developing a pipeline of risk assessment products.

Buy OVERSOLD, sell OVERBOUGHT...Deep Pockets, so when I begin buying, watch out above! TECHNICAL and FUNDAMENTAL trader..

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GENE News